These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18406197)

  • 21. [Depression in Parkinson's disease--Part 2: Therapy and management].
    Storch A; Schneider C; Ebersbach G; Fuchs G; Jost WH; Odin P; Reifschneider G; Bauer M
    Fortschr Neurol Psychiatr; 2010 Aug; 78(8):456-67. PubMed ID: 20694938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of antidepressant medication prescribing in elderly residents of aged care homes in Australia: a retrospective study.
    Nishtala PS; McLachlan AJ; Bell JS; Chen TF
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):210-9. PubMed ID: 19766953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognition and treatment of depressive symptoms in Parkinson's disease: the NPF dataset.
    Bega D; Wu SS; Pei Q; Schmidt PN; Simuni T
    J Parkinsons Dis; 2014; 4(4):639-43. PubMed ID: 25035310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Depression in Parkinson's disease: conceptual issues and clinical challenges.
    Leentjens AF
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):120-6. PubMed ID: 15312275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor.
    Miller KM; Okun MS; Fernandez HF; Jacobson CE; Rodriguez RL; Bowers D
    Mov Disord; 2007 Apr; 22(5):666-72. PubMed ID: 17266084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychometric properties of the Parkinson's Disease Sleep Scale--Brazilian version.
    Margis R; Donis K; Schönwald SV; Fagondes SC; Monte T; Martín-Martínez P; Chaudhuri KR; Kapczinski F; Rieder CR
    Parkinsonism Relat Disord; 2009 Aug; 15(7):495-9. PubMed ID: 19211294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of apathy in Parkinson's disease.
    Dujardin K; Sockeel P; Devos D; Delliaux M; Krystkowiak P; Destée A; Defebvre L
    Mov Disord; 2007 Apr; 22(6):778-84. PubMed ID: 17290451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric attributes of the Hospital Anxiety and Depression Scale in Parkinson's disease.
    Rodriguez-Blazquez C; Frades-Payo B; Forjaz MJ; de Pedro-Cuesta J; Martinez-Martin P;
    Mov Disord; 2009 Mar; 24(4):519-25. PubMed ID: 19177496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia.
    Kulisevsky J; Pagonabarraga J; Pascual-Sedano B; García-Sánchez C; Gironell A;
    Mov Disord; 2008 Oct; 23(13):1889-96. PubMed ID: 18709682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validity of Hamilton Depression Inventory in Parkinson's disease.
    Dissanayaka NN; Sellbach A; Matheson S; Marsh R; Silburn PA; O'Sullivan JD; Byrne GJ; Mellick GD
    Mov Disord; 2007 Feb; 22(3):399-403. PubMed ID: 17230471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuropsychiatric problems in patients with Parkinson's disease].
    Zhou MZ; Liu ZG; Gan J; Chen W; Lu LX; Wu JY
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1442-5. PubMed ID: 18953846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of depression in Parkinson's disease: evaluating with Zung's Self-Rating Depression Scale.
    Kanda F; Oishi K; Sekiguchi K; Kuga A; Kobessho H; Shirafuji T; Higuchi M; Ishihara H
    Parkinsonism Relat Disord; 2008; 14(1):19-23. PubMed ID: 17702629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF; Koester J; Fruh B; Shephard DT; Barone P; Houben JJ
    Clin Ther; 2009 Jan; 31(1):89-98. PubMed ID: 19243709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher incidence of depression preceding the onset of Parkinson's disease: a register study.
    Leentjens AF; Van den Akker M; Metsemakers JF; Lousberg R; Verhey FR
    Mov Disord; 2003 Apr; 18(4):414-8. PubMed ID: 12671948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bupropion as the treatment of choice in depression associated with Parkinson's disease and it's various treatments.
    Raskin S; Durst R
    Med Hypotheses; 2010 Dec; 75(6):544-6. PubMed ID: 20708340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia.
    Potvin S; Sepehry AA; Stip E
    Aust N Z J Psychiatry; 2007 Oct; 41(10):792-9. PubMed ID: 17828652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of psychiatric disorders in young-onset Parkinson's disease does not differ from typical-onset Parkinson's disease.
    Kummer A; Cardoso F; Teixeira AL
    Parkinsonism Relat Disord; 2009 Feb; 15(2):153-5. PubMed ID: 18514013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between motor subtypes and psychopathology in Parkinson's disease.
    Reijnders JS; Ehrt U; Lousberg R; Aarsland D; Leentjens AF
    Parkinsonism Relat Disord; 2009 Jun; 15(5):379-82. PubMed ID: 18977165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCOPA-sleep and PDSS: two scales for assessment of sleep disorder in Parkinson's disease.
    Martinez-Martin P; Visser M; Rodriguez-Blazquez C; Marinus J; Chaudhuri KR; van Hilten JJ; ;
    Mov Disord; 2008 Sep; 23(12):1681-8. PubMed ID: 18709672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.